John Ingrassia > Proskauer Rose LLP > Washington DC, United States > Lawyer Profile
Proskauer Rose LLP Offices
1001 PENNSYLVANIA AVE, N.W.
SUITE 600 SOUTH
WASHINGTON, DC 20004-2533
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
John Ingrassia
Work Department
Corporate
Position
John is a partner at Proskauer, advising on the full range of foreign investment and antitrust matters across industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services consumer goods and health care. He is the first call clients make in matters relating to competition and antitrust, CFIUS or foreign investment issues.
For more than 25 years, John has counselled businesses facing the most challenging antitrust issues and helped them stay out of the crosshairs — whether its distribution, pricing, channel management, mergers, acquisitions, joint ventures, or price gouging compliance.
John’s practice focuses on the analysis and resolution of CFIUS and antitrust issues related to mergers, acquisitions, and joint ventures, and the analysis and assessment of pre-merger CFIUS and HSR notification requirements. He advises clients on issues related to CFIUS national security reviews, and on CFIUS submissions when non-U.S. buyers seek to acquire U.S. businesses that have national security sensitivities. He also regularly advises clients on international antitrust issues arising in proposed acquisitions and joint ventures, including reportability under the EC Merger Regulation and numerous other foreign merger control regimes.
His knowledge, reputation and extensive experience with the legal, practical, and technical requirements of merger clearance make him a recognized authority on Hart-Scott-Rodino antitrust merger review. John is regularly invited to participate in Federal Trade Commission and bar association meetings and takes on the issues of the day.
Lawyer Rankings
United States > Antitrust > Civil litigation/class actions: defense
Proskauer Rose LLP has a strong record in defending companies in litigation across major industries including agriculture, consumer products, pharma, and sports. The team has also grown its offering and expertise in matters at the intersection of antitrust and technology law with the Antitrust Tech Task Force. Advising in cases involving allegations of price-fixing, bid rigging and monopolization, its client roster features names such as the National Football League. In Washington DC, the practice is jointly headed by Colin Kass, an antitrust and commercial litigation expert who handles the full range of antitrust and unfair competition litigation, and Christopher Ondeck, founder of the firm’s price gouging team and first-chair antitrust trial lawyer and litigator, who leads on numerous high-profile matters. Recently promoted partner John Ingrassia, based in DC, is also a key attorney and offers extensive experience in counselling businesses on antitrust issues.
Lawyer Rankings
Top Tier Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Intellectual property > Copyright
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Industry focus > Sport
- Labor and employment > Workplace and employment counseling
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Insurance > Advice to policyholders
- Investment fund formation and management > Alternative/hedge funds
- Intellectual property > Copyright
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Labor and employment > ERISA litigation
- Dispute resolution > General commercial disputes
- Tax > International tax
- Tax > Not-for-profit (nonprofit and tax exempt organizations)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Tax > US taxes: non-contentious
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Immigration
- Media, technology and telecoms > Media and entertainment: litigation
- Finance > Restructuring (including bankruptcy): corporate
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Environment > Environment: transactional
- Healthcare > Life sciences
- Media, technology and telecoms > Media and entertainment: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Securities litigation: defense
- Healthcare > Service providers
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending